Impact of Rhenium(I)-Diselenoether Compound on Cell Adhesion, Migration, Invasion Capacities, and MMP-2 Release in

Philippe Collery1, Didier Desmaele2, Adhikesavan Harikrishnan3

  • 1Société de Coordination de Recherches Thérapeutiques, Algajola, France; philippe.collery@gmail.com.

Anticancer Research
|December 31, 2024
PubMed
Abstract

Insights

Rhenium(I)-diselenoether (Re-diSe) effectively inhibits triple-negative breast cancer cell invasion and migration by reducing matrix metalloproteinase MMP-2. This metal compound shows promise in combating cancer metastasis.

Area of Science:

  • Organometallic chemistry
  • Cancer biology
  • Drug discovery

Background:

  • Organometallic complexes can inhibit cancer cell metastasis by regulating the extracellular matrix.
  • Metastasis involves cancer cell adhesion, migration, and invasion, processes often mediated by matrix metalloproteinases (MMPs).

Purpose of the Study:

  • To investigate the anti-invasive effects of a novel rhenium(I)-diselenoether (Re-diSe) compound.
  • To determine the impact of Re-diSe on matrix metalloproteinase MMP-2 in MDA-MB231 triple-negative breast cancer cells.

Main Methods:

  • Cancer cell adhesion was assessed using Matrigel.
  • Cell migration was evaluated via wound healing assays.
  • Invasion assays and MMP-2 quantification were performed using transwell assays and fluorometric kits, respectively.
  • Cells were treated with Re-diSe (5–100 μM) at various time points (48, 96, 120 h).

Main Results:

  • Re-diSe demonstrated efficacy at low concentrations (5–10 μM) across all tested assays.
  • A 120-hour exposure significantly enhanced the anti-invasive effect compared to shorter durations (48 and 96 h).

Conclusions:

  • Re-diSe exhibits significant anti-invasive properties against triple-negative breast cancer cells.
  • The compound effectively modulates MMP-2 levels, suggesting a mechanism for inhibiting cancer metastasis.